While many people report microdosing is beneficial to their mental wellbeing, researchers say more research needs to be conducted to evaluate the psychological and health implications of taking low-dose psychedelics.
A new study reports children and pre-teens who are exposed to screen time in the dark an hour before sleep are more likely to have sleep disturbances, a higher risk of anxiety and may be more prone to obesity.
Analyzing genetic data from over 48,000 people, researchers discovered higher iron levels are associated with an increased risk of cardioembolic stroke.
Researchers have successfully transplanted human brain cells into mouse brains and watched how they grow to form networks. The technique could be used to study a range of neurological conditions, the researchers report.
··4 min read
CRAFT, a new computational framework designed to aid in drug discovery, has helped researchers identify a potential new target for the treatment of epilepsy.
Researchers report DMT, the psychoactive compound of ayahuasca, can mimic actual near death experiences in healthy subjects.
Researchers say machine learning is up to 85% accurate at predicting the severity of small vessel disease, a condition associated with stroke and dementia.
According to researchers, success in big events can help boost a nation's health and wellbeing. The study, which looked at data from people whose countries participate in the Eurovision song contest, found people were 4% more likely to be satisfied with their lives with every ten place increase on the final score board. Additionally, finishing near the bottom was linked to a 13% increase in life satisfaction compared to people whose countries did not participate in the contest at all.
A new imaging technique reveals the intricacies of the brain in unprecedented detail.
Months after receiving psilocybin treatments for depression, patients report feeling more connected with nature and experience a shift away from authoritarian political views, researchers report.
Two new studies consider the potential of using psychedelics to help treat depression. Imperial College London researchers report psilocybin, the active compound in magic mushrooms, can help to relieve symptoms of depression without the dulling of emotions associated with SSRIs. The researchers note the psychedelic experience could help to maintain long term mental health for those with treatment resistant depression.
Researchers have identified mutations in the ADCY3 gene which are directly linked to obesity.
